Scientific Program - Headache
|
Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
|
| Adamantiades-Behçet's disease | The Brain and Mind in Greek Philosophy | Contursi Kindred |
Dementia |
| Epilepsy |
Headache | Multiple Sclerosis | Neuroimmunology |
| Rehabilitation / Sleep | Stroke |
| Section Heads: Dimos Mitsikostas, Greece & Alan Rapoport, USA |
|
|||
| 09:10-11:00 |
HEADACHE THERAPY
|
||
| Chairs: Michail Vikelis, Greece; Elliott Gross, USA | |||
| 9:10-10:00 | |||
| Capsule: | CGRP plays a crucial role in migraine pathophysiology. Small molecule CGRP antagonists and monoclonal antibodies to CGRP or its receptor are promising new therapies for the treatment of migraine | ||
| 9:10-9:20 |
Host: Alan Rapoport, USA
|
||
| 9:20-9:35 |
Yes: Messoud Ashina, Denmark
|
||
| 9:35-9:50 | No: Christian Lampl, Austria | ||
| 9:50-10:00 | Discussion and rebuttals | ||
| 10:00-10:50 | Proposition: Correcting the derangement in sleep architecture is sufficient to treat cluster and migraine headache without medication | ||
| Capsule: | Migraineurs and cluster headache patients who do not sleep well develop more frequent and severe headaches. Would optimal sleep therapies ever be good enough to take the place of medication for the treatment of these headaches, or is sleep impairment just an epiphenomenon? | ||
| 10:00-10:10 |
Host: Jack Schim, USA
|
||
| 1010:-10:25 |
Yes: Hans Hamburger, The Netherlands
|
||
| 10:25-10:40 | No: Oved Daniel, Israel | ||
| 10:40-10:50 |
Discussion and rebuttals | ||
| 10:50-11:00 | Cluster story: exceptions that confirm the rule |
||
| Maria-Magda Wysocka-Bakowska, Poland | |||
| 11:00-11:15 | Coffee break | ||
11:15-13:10 |
HEADACHE: BRAIN STRUCTURES |
||
| Chairs: Theodoros Constantinidis, Greece; Krystyna Mitosek-Szewczyk, Poland | |||
| 11:15-12:15 |
Debate: Structural brain changes are sufficient for accurate headache diagnosis
|
||
| Capsule: | Recent developments in brain scanning show significant differences between the primary headache types. Will this be sufficient or confirmatory for accurate diagnosis of headache types? | ||
| 11:15-11:25 |
Host: Lars Edvinsson, Sweden
|
||
| 11:25-11:40 | Yes: Anna Andreou, UK | ||
| 11:40-11:55 | No: Messoud Ashina, Denmark | ||
| 11:55-12:15 | Discussion and rebuttals | ||
| 12:15-13:10 |
Proposition: The thalamus and cortex are more critical to migraine pathophysiology than the trigeminal nerve |
||
| Capsule: | The thalamus and cortex, but also the trigeminal nerve, are involved in migraine pathophysiology; which area is most critical in the migraine process? | ||
| 12:15-12:25 | Host: Christian Lampl, Austria | ||
| 12:25-12:40 | Thalamus and cortex: Hayrunnisa Bolay, Turkey | ||
| 12:40-12:55 | Trigeminal: Lars Edvinsson, Sweden | ||
| 12:55-13:10 | Discussion and rebuttals | ||
| 15:00-17:00 |
HEADACHE
|
||
| Chairs: Nikolaos Fakas, Greece; Nataliya Pryanykova, Ukraine | |||
| 15:00-15:20 | Lecture: The Stigma of Migraine | ||
| Robert Shapiro, USA | |||
| 15:20-16:10 | Proposition: New persistent daily headache is a secondary type of headache | ||
| Capsule: | New daily persistent headache is a new headache that develops within 24 hours, persists constantly and its originating details are recalled by the patient years later. | ||
| 15:20-15:30 | Host: K. Ravishankar, India | ||
| 15:30-15:45 | Pro: Rob Cowan, USA | ||
| 15:45-16:00 | Con: Randall Weeks, USA | ||
| 16:00-16:10 | Discussion and rebuttals | ||
| 16:10-17:00 |
Proposition: Electrical stimulation will replace medications for the treatment of cluster headache
|
||
| Capsule: | Several forms of electrical stimulation have been studied for migraine and cluster. Two of them have targeted cluster headache and maybe good enough to rival medication one day. | ||
| 16:10-16:20 | Host: Dimos Mitsikostas, Greece | ||
| 16:20-16:35 | Pro: Jose Miguel Lainez, Spain |
||
| 16:35-16:50 | Con: Hayrunnisa Bolay, Turkey | ||
| 16:50-17:00 | Discussion and rebuttals | ||
| 17:00-17:15 | Coffee Break | ||
| 17:15-19:00 |
HEADACHE THERAPY
|
||
| Chairs: Panagiotis Angelidakis, Greece; George Chakhava, Georgia | |||
| 17:15-18:10 | |||
| Capsule: | The use of placebo as a control in headache trials has been questioned when efficacious treatments are already available. How critical is the placebo in clinical trials and what about ethical considerations? |
||
| 17:15-17:25 | Host: Klimentini Karageorgiou, Greece | ||
| 17:25-17:10 |
Pro: Randall Weeks, USA | ||
| 17:40-17:55 | Con: Dimos Mitsikostas, Greece | ||
| 17:55-18:10 | Discussion and rebuttals | ||
| 18:10-19:00 | Proposition: Medication overuse headache needs to be treated with detoxification so that preventive therapy can be effective in chronic migraine | ||
| Capsule: | Medication overuse headache is usually treated with detoxification from the offending agent first. There is evidence that some treatments work even prior to detoxification. | ||
| 18:10-18:20 | Host: Min Kyung Chu, South Korea | ||
| 18:20-18:35 |
Pro: K. Ravishankar, India
|
||
| 18:35-18:50 | Con: Jose Miguel Lainez, Spain | ||
| 18:50-19:00 |
Discussion and rebuttals |
||
|
|||
| PLENARY LECTURES: INVESTIGATING NEW PATHWAYS IN MIGRAINE PREVENTION | |||
| Chair: Alan Rapoport, USA | |||
| 14:00-15:00 |
• Advances in the understanding the CGRP receptor signaling pathway Lars Edvinsson, Sweden • The unmet needs of current migraine prevention Dimos Mitsikostas, Greece • What we have learned from the anti-CGRPs monoclonal antibodies development Messoud Ashina, Denmark • Q&A / Panel Discussion |
||
